Stock Analiz

LifeStance Health Group, Inc. (LFST) stock forecast and price target

Price $14.08 · data as of November 13, 2026

12-month price target

Average target$16.80
Upside / downside+19.3%
Analysts10
ConsensusBuy
Low $12.00Average $16.80High $20.00

Gold marker: average target · white marker: today’s price ($14.08)

Analyst ratings

Strong buy 2Buy 7Hold 2Sell 0Strong sell 0

Earnings and revenue estimates

PeriodEPS estimateEPS growthRevenue estimate
Current fiscal year
ends December 31, 2026
$0.40+121.2%$1.7B
Next fiscal year
ends December 31, 2027
$0.45+11.3%$2.0B
Next quarter
ends December 31, 2026
$0.10+12.7%$457M
Quarter after
ends March 31, 2027
$0.10+49.2%$462M

Consensus of the analysts covering LifeStance Health Group, updated daily. In the last 30 days 3 estimates were raised and 0 lowered.

Our model vs. Wall Street

Analysts see 19.3% upside over 12 months. Our discounted cash flow model with moderate assumptions puts LifeStance Health Group’s intrinsic value about 63% below today’s market value, and it scores 1.8 out of 5 on our checks. Price targets follow sentiment; a DCF follows cash. When both point the same way the signal is stronger. Try your own assumptions.

Frequently asked questions

What is the LifeStance Health Group stock price target?

The average 12-month target from 10 analysts is $16.80, 19.3% above the current price of $14.08 Targets range from $12.00 to $20.00.

Is LifeStance Health Group a buy according to analysts?

The consensus rating is “Buy” (2 strong buy, 7 buy, 2 hold). Ratings are opinions, not guarantees; this is not investment advice.

How much is LifeStance Health Group expected to earn?

Analysts expect EPS of $0.40 for the fiscal year ending December 31, 2026 and $0.45 the year after.

Analyst consensus estimates and price targets, updated daily. Forecasts can be wrong; this is information, not investment advice.